A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer
NCT00533533
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
docetaxel, oxaliplatin
Sponsor
Samsung Medical Center